title: Treatment by autologous amniopatch of premature rupture of membranes following mid-trimester amniocentesis.
authors.forename: L
authors.initials: L
authors.lastname: Mandelbrot
authors.forename: L
authors.initials: L
authors.lastname: Bourguignat
authors.forename: I Sahraoui
authors.initials: IS
authors.lastname: Mellouhi
authors.forename: L
authors.initials: L
authors.lastname: Gavard
authors.forename: F
authors.initials: F
authors.lastname: Morin
authors.forename: P
authors.initials: P
authors.lastname: Bierling
mesh_terms: D000328:Adult; D000649:Amniocentesis / Q000009:adverse effects*; D000650:Amnion / Q000293:injuries*; D005169:Factor VIII / Q000008:administration & dosage*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000209:etiology / Q000628:therapy*; D005340:Fibrinogen / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D017713:Platelet Transfusion; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D016896:Treatment Outcome
chemical_list: C026912:cryoprecipitate coagulum; D005169:Factor VIII; D005340:Fibrinogen